A Model to Assess the Cost Effectiveness of Statins in Achieving the UK National Service Framework Target Cholesterol Levels Koo WilsonJohn MarriottDavid Gillen Original Research Article 22 September 2012 Pages: 1 - 11
An Economic Analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS) Dean G. SmithChristopher R. McBurney Original Research Article 22 September 2012 Pages: 13 - 23
A Pharmacoeconomic Evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study in the United Kingdom Nigel BullerDavid GillenKoo Wilson Original Research Article 22 September 2012 Pages: 25 - 32
Financial and Health Costs of Uncontrolled Blood Pressure in the United Kingdom Adam LloydClaudia SchmiederNick Marchant Original Research Article 22 September 2012 Pages: 33 - 41
The Economic Burden of Stroke in the United Kingdom Penny YoumanKoo WilsonLalit Kalra Original Research Article 22 September 2012 Pages: 43 - 50